Atlas Trials

Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly

Clinical trial NCT00765323 · TERMINATED

Trial details

NCT number
NCT00765323
Sponsor
Endo USA Inc., a Keenova Therapeutics Company
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Acromegaly
Start date
2008-09-01
Primary completion
2011-02-01
Enrollment
169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.